Literature DB >> 20451576

PRKAR1A and the evolution of pituitary tumors.

Lawrence S Kirschner1.   

Abstract

Carney complex (CNC) is an inherited tumor predisposition associated with pituitary tumors, including GH-producing pituitary adenomas and rare reports of prolactinomas. This disease is caused by mutations in PRKAR1A, which encodes the type 1A regulatory subunit of the cAMP-dependent protein kinase, PKA. Loss of PRKAR1A causes enhanced PKA signaling, which leads to pituitary tumorigenesis. Mutations in the gene have not been detected in sporadic pituitary tumors, but there is some data to suggest that non-genomic mechanisms may cause loss of protein expression. Unlike CNC patients, mice heterozygous for Prkar1a mutations do not develop pituitary tumors, although complete knockout of the gene in the Pit1 lineage of the pituitary produces GH-secreting pituitary adenomas. These data indicate that complete loss of Prkar1a/PRKAR1A is able to cause pituitary tumors in mice and men. The pattern of tumors is likely related to the signaling pathways employed in specific pituitary cell types. 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20451576      PMCID: PMC2922961          DOI: 10.1016/j.mce.2010.04.027

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  50 in total

1.  Genomic mapping of chromosomal region 2p15-p21 (D2S378-D2S391): integration of Genemap'98 within a framework of yeast and bacterial artificial chromosomes.

Authors:  L S Kirschner; S E Taymans; S Pack; E Pak; B L Pike; S C Chandrasekharappa; Z Zhuang; C A Stratakis
Journal:  Genomics       Date:  1999-11-15       Impact factor: 5.736

Review 2.  Neurosurgical implications of Carney complex.

Authors:  J C Watson; C A Stratakis; P K Bryant-Greenwood; C A Koch; L S Kirschner; T Nguyen; J A Carney; E H Oldfield
Journal:  J Neurosurg       Date:  2000-03       Impact factor: 5.115

Review 3.  Clinical phenotypes and molecular genetic mechanisms of Carney complex.

Authors:  David Wilkes; Deborah A McDermott; Craig T Basson
Journal:  Lancet Oncol       Date:  2005-07       Impact factor: 41.316

4.  Prolactin secretion abnormalities in patients with the "syndrome of spotty skin pigmentation, myxomas, endocrine overactivity and schwannomas" (Carney complex).

Authors:  S B Raff; J A Carney; D Krugman; J L Doppman; C A Stratakis
Journal:  J Pediatr Endocrinol Metab       Date:  2000-04       Impact factor: 1.634

5.  p27Kip1-deficient mice exhibit accelerated growth hormone-releasing hormone (GHRH)-induced somatotrope proliferation and adenoma formation.

Authors:  L T Teixeira; H Kiyokawa; X D Peng; K T Christov; L A Frohman; R D Kineman
Journal:  Oncogene       Date:  2000-04-06       Impact factor: 9.867

6.  A mouse model for the Carney complex tumor syndrome develops neoplasia in cyclic AMP-responsive tissues.

Authors:  Lawrence S Kirschner; Donna F Kusewitt; Ludmila Matyakhina; William H Towns; J Aidan Carney; Heiner Westphal; Constantine A Stratakis
Journal:  Cancer Res       Date:  2005-06-01       Impact factor: 12.701

7.  Aryl hydrocarbon receptor activation by cAMP vs. dioxin: divergent signaling pathways.

Authors:  Barbara Oesch-Bartlomowicz; Andrea Huelster; Oliver Wiss; Patricia Antoniou-Lipfert; Cornelia Dietrich; Michael Arand; Carsten Weiss; Ernesto Bockamp; Franz Oesch
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-21       Impact factor: 11.205

8.  Proliferation of transformed somatotroph cells related to low or absent expression of protein kinase a regulatory subunit 1A protein.

Authors:  Andrea G Lania; Giovanna Mantovani; Stefano Ferrero; Caterina Pellegrini; Sara Bondioni; Erika Peverelli; Paola Braidotti; Marco Locatelli; Mario L Zavanone; Emanuela Ferrante; Silvano Bosari; Paolo Beck-Peccoz; Anna Spada
Journal:  Cancer Res       Date:  2004-12-15       Impact factor: 12.701

9.  Common genetic changes in hereditary and sporadic pituitary adenomas detected by comparative genomic hybridization.

Authors:  Svetlana D Pack; Liu-Xiu Qin; Evgenia Pak; Yun Wang; David O Ault; Poonam Mannan; Sivakumar Jaikumar; Constantine A Stratakis; Edward H Oldfield; Zhengping Zhuang; Robert J Weil
Journal:  Genes Chromosomes Cancer       Date:  2005-05       Impact factor: 5.006

10.  Mouse Prkar1a haploinsufficiency leads to an increase in tumors in the Trp53+/- or Rb1+/- backgrounds and chemically induced skin papillomas by dysregulation of the cell cycle and Wnt signaling.

Authors:  Madson Q Almeida; Michael Muchow; Sosipatros Boikos; Andrew J Bauer; Kurt J Griffin; Kit Man Tsang; Chris Cheadle; Tonya Watkins; Feng Wen; Matthew F Starost; Ioannis Bossis; Maria Nesterova; Constantine A Stratakis
Journal:  Hum Mol Genet       Date:  2010-01-15       Impact factor: 6.150

View more
  8 in total

Review 1.  Familial isolated pituitary adenomas: from genetics to therapy.

Authors:  Federica Guaraldi; Roberto Salvatori
Journal:  Clin Transl Sci       Date:  2011-02       Impact factor: 4.689

2.  Novel Mutation in PRKAR1A in Carney Complex.

Authors:  Ko Un Park; Hyun-Sook Kim; Seung Kwan Lee; Woon-Won Jung; Yong-Koo Park
Journal:  Korean J Pathol       Date:  2012-12-26

Review 3.  Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.

Authors:  Albert Beckers; Lauri A Aaltonen; Adrian F Daly; Auli Karhu
Journal:  Endocr Rev       Date:  2013-01-31       Impact factor: 19.871

Review 4.  The role of genetic and epigenetic changes in pituitary tumorigenesis.

Authors:  Hidenori Fukuoka; Yutaka Takahashi
Journal:  Neurol Med Chir (Tokyo)       Date:  2014-11-29       Impact factor: 1.742

5.  A Histopathological Study of Multi-hormone Producing Proliferative Lesions in Estrogen-induced Rat Pituitary Prolactinoma.

Authors:  Susumu Takekoshi; Yuzo Yasui; Chie Inomoto; Kanae Kitatani; Naoya Nakamura; Robert Yoshiyuki Osamura
Journal:  Acta Histochem Cytochem       Date:  2014-07-16       Impact factor: 1.938

6.  Corticotropinoma as a Component of Carney Complex.

Authors:  Laura C Hernández-Ramírez; Christina Tatsi; Maya B Lodish; Fabio R Faucz; Nathan Pankratz; Prashant Chittiboina; John Lane; Denise M Kay; Nuria Valdés; Aggeliki Dimopoulos; James L Mills; Constantine A Stratakis
Journal:  J Endocr Soc       Date:  2017-05-30

7.  The genetic heterogeneity and mutational burden of engineered melanomas in zebrafish models.

Authors:  Jennifer Yen; Richard M White; David C Wedge; Peter Van Loo; Jeroen de Ridder; Amy Capper; Jennifer Richardson; David Jones; Keiran Raine; Ian R Watson; Chang-Jiun Wu; Jiqiu Cheng; Iñigo Martincorena; Serena Nik-Zainal; Laura Mudie; Yves Moreau; John Marshall; Manasa Ramakrishna; Patrick Tarpey; Adam Shlien; Ian Whitmore; Steve Gamble; Calli Latimer; Erin Langdon; Charles Kaufman; Mike Dovey; Alison Taylor; Andy Menzies; Stuart McLaren; Sarah O'Meara; Adam Butler; Jon Teague; James Lister; Lynda Chin; Peter Campbell; David J Adams; Leonard I Zon; E Elizabeth Patton; Derek L Stemple; P Andy Futreal
Journal:  Genome Biol       Date:  2013       Impact factor: 13.583

Review 8.  Animal models of pituitary neoplasia.

Authors:  K E Lines; M Stevenson; R V Thakker
Journal:  Mol Cell Endocrinol       Date:  2015-08-28       Impact factor: 4.102

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.